v3 Template
A

Applied Pharmaceutical Innovation

Life Sciences ~1K employees
Founded
--
Employees (Est.)
~1K
74 leaders known
Total Funding
$80.5M
Funding Rounds
1
Last Funding
2023-03-17

About Applied Pharmaceutical Innovation

Applied Pharmaceutical Innovation (API) is one of Canada's largest not-for-profit life sciences commercialization organizations. Based in Edmonton with a satellite location in Calgary, API works to build and support the life sciences sector across Canada by addressing key challenges that hold companies and innovators back. They empower commercial development through fee-for-service support, programs for startups, and training for students and postdoctoral fellows.

Products & Services

CDMO Services:Investing in infrastructure, talent, and technologies to support clinical and commercial development with expert execution and precision, including Sterile Fill Finish, Oral Dosage Manufacturing, Topical Application Manufacturing, Natural Health Products, Small Molecule Manufacturing, and Highly Potent Controlled Substances.
CRO Services:Offering research development, regulatory and quality leadership, and clinical and quantitative solutions to guide innovations from early discovery through development and overcome regulatory hurdles.
Products Supported:Commercialization support for Pharmaceuticals, Medical Devices & Diagnostics, and Health Technologies.
Ecosystem Initiatives:Programs and initiatives like Training & Programs, Canadian Critical Drug Initiative, Life Sciences Week, and Life Sciences Investment Summit to foster growth in the life sciences sector.

Specialties

Commercialization of Pharmaceuticals & Biologics Medical Devices & Diagnostics Natural Health Products Health Technologies Regulatory and Quality Leadership Clinical and Quantitative Solutions Scientific and Technical Expertise

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Government Grant
T: -
FT: Government Grant
A: 80514000
MR: -
FA: 80,514,000
FAN: 80514000
D: 2023-03-17
FD: 2023-03-17
1 investors
Government Grant Latest
2023-03-17
$80.5M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Andrew MacIsaac

CEO

M

Michael Houghton

Nobel Laureate & Chief Scientific Officer

L

Launa Aspeslet

Chief Translational Officer

G

Greg Klak

Director

J

Jason Pincock

Director

H

Hari Sambasivam

Director

View 71 more team members with Pro

Unlock Full Team Directory

Recent News

Applied Pharmaceutical Innovation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences
Company Size
~1K employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro